Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Alfresa Holdings's share price for the quarter that ended in Mar. 2026 was 円2528. Alfresa Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 182 Mil. Therefore, Alfresa Holdings's market cap for the quarter that ended in Mar. 2026 was 円459,383 Mil.
Alfresa Holdings's quarterly market cap
increased
from Sep. 2025 (円384,608 Mil) to Dec. 2025 (円441,759 Mil) and
increased
from Dec. 2025 (円441,759 Mil) to Mar. 2026 (円459,383 Mil).
Alfresa Holdings's annual market cap
declined
from Mar. 2024 (円413,541 Mil) to Mar. 2025 (円383,847 Mil) but then
increased
from Mar. 2025 (円383,847 Mil) to Mar. 2026 (円459,383 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alfresa Holdings's Enterprise Value for Today is 円266,539 Mil.
Alfresa Holdings (TSE:2784) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Alfresa Holdings Market Cap Related Terms
Alfresa Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Alfresa Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Alfresa Holdings's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (TSE:2784) has a Market Cap of 円423,440 Mil as of Jul. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Alfresa Holdings and its competitors. According to the industry distribution chart, Alfresa Holdings ranks #16 out of 122 companies in the Medical Distribution industry, placing it in the top 13.1%.
Is Alfresa Holdings' Market Cap too high?
Alfresa Holdings' current Market Cap is 円423,440 Mil. Based on the distribution chart, Alfresa Holdings ranks #16 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Alfresa Holdings has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #16 out of 122 companies for Market Cap. This places Alfresa Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 134.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 134.36, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Market Cap is 134.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Market Cap is 円423,440 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (TSE:2784) is currently considered Fairly Valued. The stock's GF Value™ is 円2,542.44, compared to a current price of 円2,414.00 — trading 5.1% below its estimated fair value. The current Market Cap is 円423,440 Mil. Alfresa Holdings' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Alfresa Holdings (TSE:2784), the current Market Cap is 円423,440 Mil as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (TSE:2784) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of 円2,414.00 is trading 5.1% below its estimated GF Value™ of 円2,542.44.
GuruFocus considers Alfresa Holdings to be Fairly Valued.
Key valuation signals for TSE:2784:
Market Cap: 円423,440 Mil
GF Value™: 円2,542.44 vs. price of 円2,414.00 (5.1% below fair value)
No single metric tells the full story. See the TSE:2784 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
83GF Score
Get the complete analysis for TSE:2784
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2784 has been successfully added to your 
